TAL1 GENE DELETIONS AND TAL1 PROTEIN EXPRESSION IN SPORADIC MELANOMA

被引:2
作者
CHETTY, R
CERRONI, L
PULFORD, K
GIATROMANOLAKI, A
BIDDOLPH, S
KAKLAMANIS, L
GATTER, K
机构
[1] University Department of Cellular Science, University of Oxford, Oxford
[2] Department of Dermatology, University of Graz, Graz
[3] Department of Paediatric Pathology, John Radcliffe Hospital, Oxford
关键词
CHROMOSOME; 1P32; MELANOMA; TAL1;
D O I
10.1097/00008390-199508000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies on cytogenetic abnormalities and cell lines have implicated chromosome 1p32 as being important in the pathogenesis of melanoma, Genetic linkage studies have also mapped a melanoma-susceptibility locus to chromosome Ip, The gene TAL1 is present on chromosome 1p32, and deletions within it are the commonest chromosomal abnormality in T-acute lymphoblastic leukaemia (T-ALL), A melanoma cell line harbouring a 1p32 deletion involving the TALI gene and the presence of TAL1 protein in developing mouse melanocytes led us to investigate whether TAL1 deletions and/or TAL1 protein expression occur in sporadic melanomas, DNA extracted from 32 fresh melanomas was amplified by standard polymerase chain reaction for the four common deletions of the TAL1 gene that occur in T-ALL. In addition, frozen and paraffin-embedded sections of these melanomas were stained with monoclonal antibodies that detect full-length and truncated TAL1 protein. The results of the study show that deletions of TAL1 do not occur in melanoma. Indeed, full and truncated TAL1 protein also could not be detected immunohistochemically in the paraffin-embedded and frozen sections of the melanomas. We conclude that the TAL1 gene and its protein are probably not directly involved in the oncogenesis of melanomas.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 14 条
[1]  
Balaban G.B., Herlyn M., Clark W.M., Nowell P.C., Karyorypic evolution in human malignant melanoma, Cancer Genet Cytogenet, 19, pp. 113-122, (1986)
[2]  
Bale S.J., Dracopoli N.C., Tucker M.A., Et al., Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome lp, N Engl J Med, 320, pp. 1367-1372, (1989)
[3]  
Macintyre E.A., Smit L., Ritz J., Et al., Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor αβlineage, Blood, 80, pp. 1511-1520, (1992)
[4]  
Aplan P.D., Lombardi D.P., Reaman G., Et al., Involvement of the putative transcription factor SCL in T-cell acute lymphoblastic leukemia, Blood, 79, pp. 1327-1333, (1992)
[5]  
Pulford K., Lecointe N., Leroy-Viard K., Et al., Expression of TAL-1 proteins in human tissues, Blood, 85, pp. 675-684, (1995)
[6]  
Finger L.R., Kagan I., Christopher G., Et al., Involvement of the TCL5 gene on human chromosome 1 in T-cell acute leukemia and melanoma, Proc Natl Acad Sci USA, 86, pp. 5039-5043, (1989)
[7]  
Smith D.B., Johnson K.S., Single step purification of polypeptides expressed in Escherichia coli transferase, Gene, 67, pp. 31-40, (1988)
[8]  
Chetty R., Pulford K., Jones M., Et al., SCL Tal-1 expression in T-acute lymphoblastic leukemia an immunohistochemical and genotypic study, Hum Pathol
[9]  
Chetty R., Pulford K., Jones M., Et al., An immunohistochemical study of TALI protein expression in leukaemias and lymphomas with a novel monoclonal antibody, 2TL 242, J Pathol
[10]  
Kallianpur A.R., Jordan J.E., Brandt S.J., The SCL/tal-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis, Blood, 83, pp. 1200-1208, (1994)